Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Gross Margin: 2009-2025

Historic Gross Margin for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to 14.27%.

  • Rockwell Medical's Gross Margin fell 777.00% to 14.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.15%, marking a year-over-year decrease of 176.00%. This contributed to the annual value of 17.23% for FY2024, which is 682.00% up from last year.
  • Latest data reveals that Rockwell Medical reported Gross Margin of 14.27% as of Q3 2025, which was down 8.41% from 15.57% recorded in Q2 2025.
  • Rockwell Medical's 5-year Gross Margin high stood at 22.03% for Q3 2024, and its period low was -14.55% during Q4 2021.
  • Its 3-year average for Gross Margin is 14.09%, with a median of 14.27% in 2025.
  • As far as peak fluctuations go, Rockwell Medical's Gross Margin plummeted by 1,709bps in 2021, and later surged by 2,667bps in 2022.
  • Quarterly analysis of 5 years shows Rockwell Medical's Gross Margin stood at -14.55% in 2021, then soared by 2,667bps to 12.12% in 2022, then surged by 87bps to 12.99% in 2023, then spiked by 173bps to 14.72% in 2024, then tumbled by 777bps to 14.27% in 2025.
  • Its Gross Margin stands at 14.27% for Q3 2025, versus 15.57% for Q2 2025 and 16.08% for Q1 2025.